Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. Steven Edelman and his guest, director of clinical diabetes programs at the University of Southern California, Dr. Anne Peters, as they discuss the benefits of initiating insulin therapy for type 2 patients.
Initiating Insulin Therapy for Type 2 Diabetes
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. Steven Edelman and his guest, director of clinical diabetes programs at the University of Southern California, Dr. Anne Peters, as they discuss the benefits of initiating insulin therapy for type 2 patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE Broadcast Replay
Love Story: Lipid Education for Women’s Heart Health
0.50 credits
<p>Love Story: Lipid Education for Women’s Heart Health</p>
MinuteCE®
Biomarkers of the Storm: Decoding IRI’s Signature
0.50 credits
<p>Biomarkers of the Storm: Decoding IRI’s Signature</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
<p>Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?